The Government herein provides notice of its intent to solicit and negotiate with only one source under the authoity of 10 U.S.C. 2304(c)(1) and FAR citation 6.302-1(a)(2)(i)(A). This approval is being sought for a new cost R&D contract to the University of Texas Health Science Center (UTHSC), 7703 Floyd Curl Drive, San Antonio, TX 78229. The requirement is for a phase 2 clinical drug trial at Ft Hood, Texas to examine the efficacy of a Food and Drug Administration (FDA) licensed drug (Trazodone) that is currently prescribed off-label to treat combat-related Post Traumatic Stress Disorder (PTSD). This is not a request for competitive proposals; however, all interested parties who believe they can meet the requirements are invited to submit in writing complete information describing their ability to meet these requirements. Information received as a result of this notice will be considered solely for the purpose of determining whether to conduct a competitive procurement and will be at the sole discretion of the Contracting officer. If no written responses are received at least fifteen (15) days after the publication of this synopsis, the contract will be awarded without further notice.

Bid Protests Not Available